Two members of the QA and RA team in discussion

Quality Assurance and Regulatory Affairs Consulting

Mitigate risks and accelerate your time to market

Complex regulatory path? We know the way.

Navigating the journey from product design to regulatory clearance is no small feat. The path is riddled with obstacles that can delay your time to market and increase risks. To confidently steer through these complexities, you need a partner with deep expertise and a proven track record.

For over 25 years, our team has been the trusted ally for medical device and diagnostics companies, providing unparalleled quality assurance (QA) and regulatory affairs (RA) support. We work seamlessly with your product development and manufacturing teams to ensure compliance and keep your projects moving forward. Our strategic approach not only mitigates risks but also accelerates your time to market, giving you a competitive edge.

An Integrated Approach to Quality and Regulatory

Our quality and regulatory experts are always ahead of the curve, keeping up with ever-changing regulations so you don’t have to. Our ISO 13485 certified and FDA registered manufacturing facility guarantees that your project operates under a robust and compliant quality management system (QMS). Whether you require comprehensive QA/RA guidance or specialized expertise, our consultants craft tailored strategies that align with your goals, timeline, and budget.

Our Capabilities

Illustration of a pencil and ruler

Regulatory Strategy

StarFish guides you through the tradeoffs between business and regulatory strategies, helping you navigate market requirements to build a robust regulatory plan. We determine the best path to market for your device, including classification and submission type.

Illustration of a 3D cube

Regulatory Gap Analysis and/or Transition Planning

StarFish stays ahead of regulatory changes from FDA, Health Canada, the EU, and UK. We help you understand new requirements’ impacts on your products and processes, supporting design and documentation to maintain or achieve compliance.

Illustrations of computer and tablet

Regulatory Guidance & Training

Navigating numerous regulatory documents can be confusing. Our experts clarify expectations from regulatory bodies, ensuring your products and processes meet standards. We offer engaging training materials and regularly support conferences and university lectures.

Illustration of a microscope

Pre-sub Submissions

Engage with the FDA through the free pre-sub program to de-risk your project. We craft critical questions, compile necessary documentation, handle submission requests, and support meetings and feedback responses.

Illustration of a delivery truck

Clinical Submissions

Whether you need an IDE for a US trial or an ITA for a Canadian trial, we provide documentation and guidance. We have connections with BC clinical trials and can recommend ethics boards if needed.

Illustration of two speech bubbles

Product Submissions

From strategy to submission, StarFish supports your entire product development process. We have experience with FDA, Health Canada, and EU notified body submissions.

Illustration of a 3D cube

QMS Design & Implementation

StarFish helps develop your QMS alongside product development. We align your corporate structure with QMS requirements (QMSR, ISO 13485, MDSAP, MDR/IVDR). We draft QMS documents or support your SMEs in developing them, and provide independent review and auditing support. We also assist in selecting, implementing, and validating electronic systems.

Illustrations of computer and tablet

Mock Audit & Independent Review

Gain additional perspective with StarFish’s auditing services. We review your processes before regulatory submission, offering insights into operational excellence and compliance. We also provide independent reviews, especially useful for small teams.

Chart Your Course with Expert Regulatory Affairs Consulting

Navigating the approval process for medical devices can be complex, with multiple paths to choose from. Our QA/RA consultants are here to guide you, identifying the route that best aligns with your business strategy. Leveraging extensive knowledge of the latest regulatory requirements and years of communication with regulators, we ensure your decisions are well-informed and strategically sound.

Expertise to Navigate Global Regulatory Landscapes

  • Extensive experience with the FDA, EU notified bodies, Health Canada, and other regulatory authorities worldwide
  • In-depth regulatory research to understand and apply relevant requirements
  • Strategic regulatory planning tailored to your business needs
  • ISO 13485 implementation consulting for robust quality management systems
  • Accurate classification and predicate identification
  • Expert regulatory input integrated into design requirements
  • Continuous monitoring to identify and address regulatory changes impacting your projects
  • Comprehensive regulator communications and support, including FDA Q-Submission and Pre-Submission programs
  • Preparation and submission of complete regulatory packages

Stay the Course with Quality Assurance and QMS Support

QA is embedded in all we do. Our team remains fully engaged in your project, so you can be confident that you’ll arrive with a safe, effective, and compliant product.

Our experience includes:

  • QMS design, implementation, and maintenance
  • Verification and validation support
  • IEC 60601 safety certification support
  • Writing project-specific quality documentation
  • Requirements generation and risk management support
  • Ensuring traceability throughout DHF documentation
  • Reviewing documentation to ensure regulatory success
  • Providing guidance and solutions to quality challenges
  • ECR/NCR process compliance and impact assessment
  • Quality controls on prototypes and product builds to ensure safe and effective product release
  • Biocompatibility assessments, sterilization efficacy and validation studies, and other third-party testing

What Our Clients Have to Say

Ian Maclean

Ian Maclean

Project Manager
Koven Technology Canada

I commend you for your vision in looking well ahead to regulatory and contract assembly issues, as well as a decision to concurrently develop key prototypes. This ultimately led to a successful design concept. All initial design requirements were satisfied.

Michael Baker

Michael Baker

CEO
Otoharmonics Corporation

“I am extremely happy with StarFish support while setting up a QMS for Otoharmonics and the Levo System tinnitus sound therapy device. I’ve worked with a lot of QMS people in my life and the StarFish team are the most helpful and easy to work with.”

QA/RA Across the Product Lifecycle

QA/RA input spans all stages of product development. By gaining a clear understanding of your business needs and product goals, StarFish supports you through the peaks and valleys of quality and regulatory activities.

Impact of New FDA Laboratory Developed Tests Policy

Published under: Resources
The U.S. Food and Drug Administration (FDA) made a significant update to its regulatory approach for in vitro diagnostic products (IVDs), including laboratory developed tests (LDTs). Detailed in a FDA Laboratory Developed Tests Policy guidance document issued on June 25,…
FDA Laboratory Developed Tests Policy

Explore Our Services

Illustration of a pencil and ruler

Our multidisciplinary teams have all the in-house capabilities to transform your medical device from concept to final product.

Illustration of a 3D cube

Medical device design and development with a commercial launch focus. See how we support clinical trials and facilitate seamless tech transfers.

Root Cause Analysis

Overview of tools for Root Cause Analysis is an important tool in medical device development and manufacturing.

Predetermined Change

Predetermined Change Control Plans (PCCPs) Draft Guidance with Implications for Medical Device Manufacturers and regulatory framework

FDA Laboratory Developed Tests Policy

The U.S. Food and Drug Administration (FDA) made a significant update to its regulatory approach for in vitro diagnostic products (IVDs), including laboratory developed tests (LDTs). Detailed in a FDA Laboratory Developed Tests Policy guidance document issued on June 25, 2024.